Changzhou Qianhong Biopharma CO.,LTD
SHZ: 002550.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ke Wang
- Employees
- 979
- Headquarters
- Changzhou, China
- IPO year
- 2011
- Market cap
- CN¥8.7B
- Website
- https://www.qhsh.com.cn
Loading 002550…
Loading profile data…Frequently asked questions about 002550
What does Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) do?
Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as antic...
Where does 002550.SZ trade?
Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002550.SZ in?
Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Changzhou Qianhong Biopharma CO.,LTD?
Ke Wang is the chief executive officer of Changzhou Qianhong Biopharma CO.,LTD (002550.SZ).
Where is Changzhou Qianhong Biopharma CO.,LTD headquartered?
Changzhou Qianhong Biopharma CO.,LTD is headquartered in China.
Does 002550.SZ pay a dividend?
Yes — Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) paid a trailing twelve-month dividend of CNY 0.12 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002550.SZ go public?
Changzhou Qianhong Biopharma CO.,LTD (002550.SZ) completed its initial public offering in 2011.